David A Bennett Selected Research

complexin I

5/2021	Tripartite Relationship Among Synaptic, Amyloid, and Tau Proteins: An In Vivo and Postmortem Study.
1/2019	The synaptic pathology of cognitive life .
1/2017	Presynaptic proteins complexin-I and complexin-II differentially influence cognitive function in early and late stages of Alzheimer's disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

David A Bennett Research Topics

Disease

229	Alzheimer Disease (Alzheimer's Disease) 11/2022 - 02/2002
146	Cognitive Dysfunction 04/2022 - 02/2002
95	Dementia (Dementias) 07/2022 - 02/2002
25	Amyloid Plaque 01/2022 - 05/2004
24	Hippocampal Sclerosis 06/2022 - 11/2013
20	Infarction (Infarctions) 01/2022 - 01/2012
16	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022 - 08/2005
13	Cerebral Amyloid Angiopathy (Congophilic Angiopathy) 06/2022 - 07/2012
12	Atherosclerosis 10/2022 - 01/2017
12	Cerebral Infarction 12/2020 - 01/2006
10	Arteriolosclerosis 01/2022 - 08/2017
9	Inflammation (Inflammations) 01/2022 - 01/2013
8	Parkinsonian Disorders (Parkinsonism) 10/2022 - 11/2005
8	Neuroinflammatory Diseases 07/2022 - 04/2016
7	Atrophy 01/2022 - 05/2014
7	Brain Diseases (Brain Disorder) 01/2022 - 10/2020
7	Disease Progression 09/2021 - 10/2007
7	Stroke (Strokes) 04/2021 - 03/2005
7	Parkinson Disease (Parkinson's Disease) 01/2021 - 03/2005
7	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2021 - 01/2011
6	Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar) 02/2022 - 03/2010
6	Vascular Diseases (Vascular Disease) 01/2022 - 02/2007
5	Proteostasis Deficiencies 07/2022 - 11/2016
5	Brain Infarction 01/2022 - 01/2013
5	limbic-predominant age-related TDP-43 encephalopathy 01/2022 - 10/2020
5	Memory Disorders (Memory Loss) 01/2019 - 04/2005
4	Intracranial Arteriosclerosis (Cerebral Atherosclerosis) 10/2022 - 01/2020
4	Amyloidosis 03/2022 - 01/2018
4	Genetic Risk Score 01/2022 - 04/2015
4	Frailty 01/2022 - 08/2008
4	Amyloid angiopathy 01/2021 - 11/2015
4	Chronic Disease (Chronic Diseases) 01/2020 - 08/2008
4	Synucleinopathies 01/2018 - 08/2005
4	Lewy Body Disease (Lewy Body Dementia) 01/2017 - 04/2014
3	Pathologic Processes 01/2021 - 01/2017
3	TDP-43 Proteinopathies 01/2021 - 01/2018
3	Hypertension (High Blood Pressure) 01/2019 - 10/2014
3	Coronary Artery Disease (Coronary Atherosclerosis) 01/2019 - 06/2005
3	Pain (Aches) 08/2013 - 09/2010
2	Cardiovascular Diseases (Cardiovascular Disease) 12/2021 - 01/2020

Drug/Important Bio-Agent (IBA)

71	Amyloid (Amyloid Fibrils)IBA 01/2022 - 03/2004
68	Apolipoproteins E (ApoE)IBA 11/2022 - 05/2004
55	Proteins (Proteins, Gene)FDA Link 05/2022 - 08/2003
35	Biomarkers (Surrogate Marker)IBA 03/2022 - 10/2005
33	DNA-Binding Proteins (DNA Binding Protein)IBA 01/2022 - 03/2010
31	ApolipoproteinsIBA 11/2022 - 02/2003
19	Amyloid beta-PeptidesIBA 10/2022 - 01/2007
14	Messenger RNA (mRNA)IBA 01/2022 - 09/2004
12	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2016
12	Biological ProductsIBA 01/2022 - 07/2006
11	CholesterolIBA 07/2022 - 01/2005
10	Pharmaceutical PreparationsIBA 01/2022 - 09/2013
9	Peptides (Polypeptides)IBA 03/2022 - 12/2011
7	Apolipoprotein E4IBA 01/2022 - 05/2008
7	Cholinergic Agents (Cholinergics)IBA 10/2021 - 02/2002
6	SilverIBA 06/2022 - 05/2006
6	Indicators and Reagents (Reagents)IBA 09/2021 - 01/2006
6	SynucleinsIBA 01/2021 - 07/2012
6	Protein Isoforms (Isoforms)IBA 01/2020 - 02/2008
6	MicroRNAs (MicroRNA)IBA 01/2020 - 01/2015
6	EnzymesIBA 10/2016 - 02/2003
5	LipidsIBA 12/2021 - 08/2009
5	DNA (Deoxyribonucleic Acid)IBA 10/2021 - 09/2014
5	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2021 - 04/2005
4	ProteomeIBA 01/2022 - 01/2021
4	CalciumIBA 01/2022 - 01/2021
4	Nerve Growth Factor (NGF)IBA 10/2021 - 08/2003
4	Hemoglobins (Hemoglobin)IBA 04/2021 - 01/2012
4	Insulin (Novolin)FDA Link 01/2021 - 01/2018
4	AntibodiesIBA 01/2019 - 08/2011
4	Caspase 6IBA 12/2016 - 09/2004
4	Antipsychotic Agents (Antipsychotics)IBA 08/2008 - 11/2005
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 10/2022 - 05/2014
3	Phospholipases A2 (Phospholipase A2)IBA 01/2022 - 01/2021
3	complexin IIBA 05/2021 - 01/2017
3	complexin IIIBA 05/2021 - 01/2017
3	Bile Acids and Salts (Bile Acids)IBA 01/2021 - 01/2019
3	C-Reactive ProteinIBA 01/2019 - 01/2013
3	ChromatinIBA 01/2019 - 01/2014
3	Complement System Proteins (Complement)IBA 01/2019 - 04/2009
3	Coloring Agents (Dyes)IBA 01/2017 - 05/2006
3	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 10/2016 - 09/2004
3	Antihypertensive Agents (Antihypertensives)IBA 03/2016 - 01/2006
3	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 01/2016 - 07/2003
3	UbiquitinIBA 04/2014 - 01/2004
3	Choline O-Acetyltransferase (Choline Acetyltransferase)IBA 03/2005 - 02/2002
2	Complement C4 (Complement Component 4)IBA 11/2022 - 10/2021
2	Neurotransmitter Agents (Neurotransmitter)IBA 07/2022 - 01/2020
2	LDL CholesterolIBA 06/2022 - 12/2021
2	oxidized low density lipoproteinIBA 06/2022 - 01/2019
2	ProgranulinsIBA 02/2022 - 03/2010
2	Anthocyanins (Anthocyanin)IBA 01/2022 - 12/2019
2	pelargonidinIBA 01/2022 - 12/2019
2	AntioxidantsIBA 01/2022 - 06/2002
2	Immunoglobulins (Immunoglobulin)IBA 04/2021 - 01/2021
2	Phosphotransferases (Kinase)IBA 01/2021 - 10/2015

Therapy/Procedure

13	Activities of Daily Living (ADL) 01/2022 - 10/2006
10	Therapeutics 01/2021 - 02/2002
5	Dietary Approaches To Stop Hypertension 07/2022 - 09/2015
2	Mediterranean Diet 01/2021 - 10/2014